Showing results (111-120 of 237) with videos related to

Sort By:
Pageof 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2019
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and SwitzerlandDaniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, et al.
Plos Pathogens|October 15, 2024
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infectionMichael Schoefbaenker, Theresa Günther, Eva Ulla Lorentzen, et al.
Bone Marrow Transplantation|December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemiaKlaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
Bone Marrow Transplantation|May 29, 2025
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMTArnon Nagler, Allain-Thibeault Ferhat, Sarah Kayser, et al.
British Journal of Haematology|February 23, 2018
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemiaNina K Steckel, Christoph Groth, Jan-Henrik Mikesch, et al.
Annals of Hematology|March 24, 2019
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)Torsten Kessler, Steffen Koschmieder, Christoph Schliemann, et al.
Bone Marrow Transplantation|November 22, 2025
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMTKordelia Barbullushi, Myriam Labopin, Nicolaus Kröger, et al.
Bone Marrow Transplantation|March 30, 2024
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Myriam Labopin, Nicolaus Kröger, et al.
Genome Medicine|June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapyI-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Cancer Immunology Research|February 13, 2015
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantationChristoph Schliemann, Katrin L Gutbrodt, Andrea Kerkhoff, et al.
Pageof 24